Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy

Mazzaferri, 2001, Current approaches to primary therapy for papillary and follicular thyroid cancer, J Clin Endocrinol Metab, 86, 1447, 10.1210/jcem.86.4.7407

Schlumberger, 2003, Non toxic goiter and thyroid neoplasia, In: Larsen RP, Kronenberg HM, Melmed S, Polonsky KS, eds. Williams’ textbook of endocrinology. 10th ed. Philadelphia: WB Saunders Company;, 457

Maxon, 1990, Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer, Endocrinol Metab Clin N Am, 19, 685, 10.1016/S0889-8529(18)30317-7

Robbins, 2005, The evolving role of 131I for the treatment of differentiated thyroid carcinoma, J Nucl Med, 46, 28S

Bernier, 2001, Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas, J Clin Endocrinol Metab, 86, 1568, 10.1210/jcem.86.4.7390

Smit, 2000, Embolization for vertebral metastases of follicular thyroid carcinoma, J Clin Endocrinol Metab, 85, 989, 10.1210/jcem.85.3.6436

Tubiana, 1985, External radiotherapy in thyroid cancers, Cancer, 55, 2062, 10.1002/1097-0142(19850501)55:9+<2062::AID-CNCR2820551406>3.0.CO;2-O

Schlumberger, 1996, Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma, J Nucl Med, 37, 598

Casara, 1993, Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables, J Nucl Med, 34, 1626

Dinneen, 1995, Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades, J Clin Endocrinol Metab, 80, 2041

Hindie, 2003, Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?, Eur J Nucl Med Mol Imaging, 30, 974, 10.1007/s00259-003-1174-5

Lin, 2004, Papillary thyroid carcinomas with lung metastases, Thyroid, 14, 1091, 10.1089/thy.2004.14.1091

Nemec, 1979, Radioiodine treatment of pulmonary metastases of differentiated thyroid cancer. Results and prognostic factors, Nuklearmedizin, 18, 86, 10.1055/s-0037-1620881

Pacini, 1994, Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine, World J Surg, 18, 600, 10.1007/BF00353775

Pittas, 2000, Bone metastases from thyroid carcinoma: clinical characteristics and prognostic variables in one hundred forty-six patients, Thyroid, 10, 261, 10.1089/thy.2000.10.261

Rubino, 2003, Second primary malignancies in thyroid cancer patients, Br J Cancer, 89, 1638, 10.1038/sj.bjc.6601319

Kloos, 2002, Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma, J Clin Endocrinol Metab, 87, 5817, 10.1210/jc.2002-020210

Mandel, 2003, Radioactive iodine and the salivary glands, Thyroid, 13, 265, 10.1089/105072503321582060

Shimaoka, 1985, Randomized trial of Doxorubicin versus Doxorubicin plus Cisplatin in patients with advanced thyroid carcinoma, Cancer, 56, 2155, 10.1002/1097-0142(19851101)56:9<2155::AID-CNCR2820560903>3.0.CO;2-E

Williams, 1986, Phase II evaluation of Doxorubicin plus Cisplatin in advanced thyroid cancer: a Southeastern Cancer Study Group Trial, Cancer Treat Rep, 70, 405

Braga-Brasaria, 2003, Beyond radioiodine: a review of potential new therapeutic approaches for thyroid cancer, J Clin Endocrinol Metab, 88, 1947, 10.1210/jc.2002-021863

Reiners, 2003, Radioiodine therapy in patients with pulmonary metastases of thyroid cancer: when to treat, when not to treat?, Eur J Nucl Med Mol Imaging, 30, 939, 10.1007/s00259-003-1219-9

Robbins, 2006, Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography, J Clin Endocrinol Metab, 91, 498, 10.1210/jc.2005-1534

Hedinger, 1988, 11

Rosai, 1996

Biondi, 2005, Thyroid-hormone therapy and thyroid cancer: a reassessment, Nat Clin Pract Endocrinol Metab, 1, 32, 10.1038/ncpendmet0020

Demers, 2003, Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease, Thyroid, 13, 4

Schlumberger, 1997, 131I therapy for elevated thyroglobulin levels, Thyroid, 7, 273, 10.1089/thy.1997.7.273

Park, 1994, Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131, Thyroid, 4, 49, 10.1089/thy.1994.4.49

Droz, 1990, Chemotherapy in metastatic nonanaplastic thyroid cancer: experience at the Institut Gustave-Roussy, Tumori, 76, 480, 10.1177/030089169007600513

Becker, 1982, Current status of radioiodine (131I) treatment of hyperthyroidism, In: Freeman LM, Miller JM, eds. Nuclear medicine annual. New York: Raven Press;, 265

Baudin, 2003, Positive predictive value of serum thyroglobulin levels, measured during the first year of follow up after thyroid hormone withdrawal, in thyroid cancer patients, J Clin Endocrinol Metab, 88, 1107, 10.1210/jc.2002-021365

Pacini, 2001, Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic 131I whole body scan: comparison of patients treated with high 131I activities versus untreated patients, J Clin Endocrinol Metab, 86, 4092, 10.1210/jcem.86.9.7831